Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
US Anti-Snoring Devices and Snoring Surgery Market Size, Share, Growth, Trends, and Industry Analysis: By Device, Tongue-Retaining Devices, Nasal Dilator, Chin Strap, Position Control, Tongue Stabilizing Devices, Expiratory Positive Airway Pressure), By Surgical Procedure, By Distribution Channel and Country
The US anti-snoring devices and snoring surgery market size was valued at US$ 538.6 million in 2023 and is projected to reach US$ 917.1 million by 2030, growing at a CAGR of 7.9% from 2024 to 2030. The U.S. Anti-Snoring Devices and Snoring Surgery market is being fuelled by awareness about sleep disorders, obesity that is catching up, technological advancement, and an aging population.
The prevalence of sleep apnea exists for approximately 30 million Americans and is one of the popular solutions sought by patients as the NIH has rightly increased funding to $400 million for the study of sleep disorders. High costs, limited insurance coverage, and compliance of patients have restricted market growth. Acceptance of home sleep tests and telemedicine brings with it opportunities that promote the demand for non-invasive treatments, propelled by interest in health and wellness. Among such trends are those related to AI-powered smart devices, personalized appliances, minimally invasive surgeries, and public funds supporting the development of telemedicine and efforts in wellness.
SomnoMed Ltd, Airway Management, Inc, Resmed Inc, Pure Sleep Company, Biotronik Se & Co. Kg, Meditas Ltd, Sleeping Well, LLC, Somnomed Limited, The Pure Sleep Company, Tomed Dr. Toussaint Gmbh, Apnea Sciences Corporation, Theravent, Inc., GlaxoSmithKline, PLC and among others
By Device: Mandibular Advancement Devices (MADs)are currently the most widely adopted, dominating segment due to their effectiveness in mild to moderate obstructive sleep apnea (OSA) cases. MADs are popular as they reposition the jaw to prevent airway obstruction, reducing snoring and improving sleep quality.
By Surgical Procedure: Uvulopalatopharyngoplasty (UPPP)remains the most performed surgical procedure. UPPPis an established treatment for chronic snoring and sleep apnea, usually done after failing other treatment interventions, so it becomes a reliable intervention.
By Distribution Channel: Hospitals lead in this segment due to their comprehensive range of treatment options and specialized facilities for complex cases, including surgeries and advanced diagnostics.
Some elements of the U.S. population start becoming more aware of sleep disorders, such as snoring and sleep apnea. The AASM reports that an estimated nearly 30 million Americans have obstructive sleep apnea, most undiagnosed. Public campaigns by the CDC want to expand public awareness of how poor-quality sleep is connected with chronic diseases; thus, demand for anti-snoring solutions is increased. Innovations are being funded by the government.
For instance, the NIH annually invests more than $400 million in studies related to sleep disorders, which continues to advance anti-snoring products. Obesity is a significant contributor to snoring. The CDC states that approximately 42% of U.S. adults are obese, a factor linked to increased snoring risk due to airway obstruction. This epidemic has driven demand for anti-snoring devices, as individuals seek solutions to mitigate snoring-related health risks. Public health programs addressing obesity indirectly boost demand for anti-snoring interventions.
Technology has resulted in high-tech anti-snoring appliances, including smart wearables and mobile-controlled appliances. These innovations enhance comfort and effectiveness as they help patients effectively manage snoring and sleep apnea. Such research funding that NIH and FDA have supported advanced anti-snoring devices results in effective treatment; therefore, treatments become accessible and appealing. The number of older adults in the U.S. is growing, and this is a resultant rise in sleep-related disorders, such as snoring. According to the U.S. Census Bureau, the geriatric population will be doubled by 2060, thus increasing the necessity for anti-snoring devices and treatments.
Surgical anti-snoring treatments may be quite expensive, at anywhere between $3,000-$5,000. The lack of insurance coverage would significantly limit the growth of this market because many patients cannot afford the surgery due to financial constraints and usually prefer non-surgical remedies. Some anti-snoring surgeries and devices may also cause discomfort, dry mouth, or other side effects. So, most patients, being well aware of such side effects, may refrain from opting for surgical or device-based treatments. Many insurance plans classify anti-snoring treatments as elective, limiting coverage. Consequently, patients bear out-of-pocket costs, hindering market growth. Legislative efforts to extend coverage to sleep-related treatments have yet to make significant progress. Non-compliance, particularly with CPAP (Continuous Positive Airway Pressure) machines, limits effectiveness. Studies show that up to 50% of patients struggle with long-term CPAP use, impacting demand.
Home sleep tests offer an accessible, affordable way to diagnose snoring issues, increasing awareness and demand for treatment. The FDA’s recent approval of at-home testing kits makes diagnosis more accessible, and Medicare has expanded coverage for these tests, driving market growth. Non-invasive options like nasal strips and chin straps have gained popularity. Demand for alternatives to CPAP is rising, prompting innovation in new devices. Telemedicine enables remote diagnosis and consultation for sleep disorders, which reduces healthcare costs and improves patient access. Federal investments, such as the $200 million CARES Act telehealth funding, have accelerated telemedicine, boosting market potential. A growing interest in wellness supports proactive approaches to sleep health. U.S. wellness spending is estimated to grow 5-10% annually, and snoring treatment solutions are becoming part of preventive health.
Smart anti-snoring devices with AI guarantee personalized therapy adjustment and user experience. FDA-approved AI devices have grown 40% since 2020, a reflection of growing interest. Custom-fitted appliances increase comfort and compliance and patients love them. Dentists and sleep specialists increasingly work in concert with each other to develop tailored devices, thus enhancing effectiveness. In addition, the market is strengthened by partnerships between device manufacturers and healthcare providers. Mergers, like those recently finalized between ResMed, demonstrate growth and enhance sleep health focus. Minimally invasive surgical procedures, including laser-assisted ones, include a reduced recovery time and decreased complications and attract patients looking for alternatives to CPAP.
Report Benchmarks |
Details |
Market Size in 2023 |
US$ 538.6 million |
Market Size in 2030 |
US$ 917.1 million |
By Device |
|
By Surgical Procedure |
|
By Distribution Channel |
|
By Region |
|
U.S. Anti-Snoring Devices and Snoring Surgery Market--one of the most promising, high-growth sectors that will be driven by increased awareness of sleep disorder conditions and by technological advancements. Increased rates of obesity are especially widespread among older age groups and stimulate demand for both device-based and surgical solutions. High cost, limited insurance coverage, and low compliance with CPAP remain major obstacles. Even as the market is shifting toward AI-integrated smart devices, telemedicine, and non-invasive solutions are part of an expanding wellness trend-strategic partnerships among providers with innovative technologies will accelerate the growth of the market even further, meeting demand in the coming years for more accessible and effective anti-snoring solutions.
Download Free Sample Report
The US anti-snoring devices and snoring surgery market size was valued at US$ 538.6 million in 2023 and is projected to reach US$ 917.1 million by 2030, growing at a CAGR of 7.9% from 2024 to 2030.
• AI-Driven and Smart Snoring Solutions
• Rising Demand for Customized Devices
• Partnerships and Mergers in the Market
• Growth in Minimally Invasive Surgical Procedures
• Growing Awareness of Sleep Disorders
• Rising Incidence of Obesity
• Technological Advancements
• Increasing Geriatric Population
• High Cost of Surgical Procedures
• Side Effects and Complications
• Lack of Insurance Coverage
• Patient Compliance
Uvulopalatopharyngoplasty surgical procedures have the highest share in the anti-snoring devices and snoring surgery market.
1. Executive Summary |
2. U.S. Anti-Snoring Devices and Snoring Surgery Market Introduction |
2.1. U.S. Anti-Snoring Devices and Snoring Surgery Market Taxonomy |
2.2. U.S. Anti-Snoring Devices and Snoring Surgery Market Definitions |
2.2.1. Device |
2.2.2. Surgical Procedure |
2.2.3. Distribution Channel |
3. U.S. Anti-Snoring Devices and Snoring Surgery Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. U.S. Anti-Snoring Devices and Snoring Surgery Market Dynamic Factors - Impact Analysis |
3.6. U.S. Anti-Snoring Devices and Snoring Surgery Market Competition Landscape |
4. U.S. Anti-Snoring Devices and Snoring Surgery Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. U.S. Anti-Snoring Devices and Snoring Surgery Market Forecast, By Device, 2019 - 2023 and Forecast, 2024 - 2030 |
5.1. Oral Devices |
5.1.1. Mandibular Advancement Devices (MADS) |
5.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3. Market Opportunity Analysis |
5.1.2. Tongue-Retaining Devices (TRDS) |
5.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.2. Nasal Dilator |
5.2.1. External Nasal Dilators (Nasal Strips) |
5.2.2. Other Nasal Devices (Nasal Stents, Nasal Clips, and Septal Stimulators) |
5.3. Chin Strap |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Position Control |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Tongue Stabilizing Devices |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Expiratory Positive Airway Pressure |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
6. U.S. Anti-Snoring Devices and Snoring Surgery Market Forecast, By Surgical Procedure, 2019 - 2023 and Forecast, 2024 - 2030 |
6.1. Uvulopalatopharyngoplasty |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Pillar Procedure |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Laser-Assisted Uvulopalatoplasty |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Radiofrequency Ablation |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Sclerotherapy |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Septoplasty |
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Palatal Stiffening Procedures |
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
6.8. Injection Snoreplasty/Sclerotherapy |
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.8.3. Market Opportunity Analysis |
6.9. U.S. Anti-Snoring Devices and Snoring Surgery Market - Opportunity Analysis Index, By Device, By Surgery, By Distribution Channel, and Region, 2024 - 2030 |
7. U.S. Anti-Snoring Devices and Snoring Surgery Market Forecast, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2030 |
7.1. Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Clinics |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, US$ Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. U.S. Anti-Snoring Devices and Snoring Surgery Market - Opportunity Analysis Index, By Device, By Surgery, By Distribution Channel, and Region, 2022 2028 |
9. Competition Landscape |
9.1. Strategic Dashboard of Top Market Players |
9.2. Company Profiles (Introduction, Financial Analysis, Feedstock Material & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
9.2.1. Pure Sleep Company |
9.2.2. Airway Management Inc. |
9.2.3. Biotronik Se & Co. Kg |
9.2.4. Recent Developments |
9.2.5. Meditas Ltd |
9.2.6. Sleeping Well, LLC |
9.2.7. Somnomed Limited |
9.2.8. The Pure Sleep Company |
9.2.9. Tomed Dr. Toussaint Gmbh |
9.2.10. Apnea Sciences Corporation |
9.2.11. Theravent, Inc. |
9.2.12. Glaxosmithkline, PLC |
10. Research Methodology |
11. Key Assumptions and Acronyms |
Key Market Players